
Inner Harbor-based biotech company PathSensors develops tests for pathogens using technology licensed from MIT-Lincoln Laboratory, called CANARY. Using genetically engineered biosensors, or immune cells, the tests can detect the presence of a disease-producing agent in a specific environment.
Now it is turning its focus toward the disease-causing agent behind the new coronavirus.
This week, PathSensors said it’s developing a biosensor that will be designed to detect the pathogen associated with the new coronavirus that is causing the global pandemic. The test, which will be using the CANARY technology that emits light when a pathogen is found, is being developed to detect the coronavirus in five minutes.
READ FULL ARTICLE HERE

